Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-06

Clinical Trial Update: Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography [NA]

View source ↗

Summary

Clinical trial update describing recruitment for a study evaluating PCSK9 inhibitors to improve lipid-lowering and cardiovascular outcomes in high-risk coronary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PCSK9 inhibitors

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Coronary Artery Disease, CT Angiography | NA | Status: RECRUITING